शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSETITAN SECURITIES LTD.· FinanceHighNeutral
Announced Thu, 13 Aug, 2026 · 17:32 IST

Titan Securities Q1 FY27: standalone swings to loss, consolidated PAT jumps 63%

Revenue declinedNet loss reportedResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.4%Reaction day
₹41.61
prior close
₹43.99
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.5% vs market
Non Banking Financial Company (NBFC) peers, median of 210sector-0.4%-0.0% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and in line with its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-6.0
10m
-2.4
15m
-4.5
30m
-4.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.4+0.1-0.5-0.4-0.0
Next day
-1.6+0.2-1.8-0.7-0.9
2d
-2.3+0.6-2.9-1.3-1.0
3d
-2.2-0.0-2.2-1.8-0.3
4d
-1.7+0.5-2.2-1.6-0.1
5d
-0.6+0.8-1.4-1.1+0.5
1w
-0.1+0.6-0.7-1.2+1.0
15d
+1.1+1.3-0.2-0.9+1.9
1m
-2.9-1.4-1.6-3.1+0.2
2m
-11.9-0.6-11.3-4.4-7.4
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 210Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Titan Securities posted standalone revenue of Rs 58.36 lakh in Q1 FY27, down 39% from Rs 96.07 lakh a year ago, and slipped into a loss of Rs 1.51 lakh versus a Rs 4.18 lakh profit. On a consolidated basis, PAT jumped to Rs 454.95 lakh from Rs 278.34 lakh, lifted by a Rs 456.46 lakh share of profit from associates Titan Biotech and Peptech Biosciences. The board also appointed Ranjeet Kumar as CFO effective August 13, 2026.

Likely market impact

Standalone core business is weak with falling revenue and a loss, but strong associate earnings drive consolidated profit growth; new CFO appointed.